212 related articles for article (PubMed ID: 23675542)
1. IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety.
Guerbois M; Volkova E; Forrester NL; Rossi SL; Frolov I; Weaver SC
PLoS Negl Trop Dis; 2013; 7(5):e2197. PubMed ID: 23675542
[TBL] [Abstract][Full Text] [Related]
2. IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.
Rossi SL; Guerbois M; Gorchakov R; Plante KS; Forrester NL; Weaver SC
Virology; 2013 Mar; 437(2):81-8. PubMed ID: 23351391
[TBL] [Abstract][Full Text] [Related]
3. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.
Atasheva S; Kim DY; Frolova EI; Frolov I
J Virol; 2015 Jan; 89(1):71-82. PubMed ID: 25320296
[TBL] [Abstract][Full Text] [Related]
4. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.
Tretyakova I; Lukashevich IS; Glass P; Wang E; Weaver S; Pushko P
Vaccine; 2013 Feb; 31(7):1019-25. PubMed ID: 23287629
[TBL] [Abstract][Full Text] [Related]
5. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
[TBL] [Abstract][Full Text] [Related]
6. IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge.
Rossi SL; Russell-Lodrigue KE; Killeen SZ; Wang E; Leal G; Bergren NA; Vinet-Oliphant H; Weaver SC; Roy CJ
PLoS Negl Trop Dis; 2015 May; 9(5):e0003797. PubMed ID: 26020513
[TBL] [Abstract][Full Text] [Related]
7. Stability of RNA virus attenuation approaches.
Kenney JL; Volk SM; Pandya J; Wang E; Liang X; Weaver SC
Vaccine; 2011 Mar; 29(12):2230-4. PubMed ID: 21288800
[TBL] [Abstract][Full Text] [Related]
8. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
[TBL] [Abstract][Full Text] [Related]
9. Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge.
Tretyakova I; Plante KS; Rossi SL; Lawrence WS; Peel JE; Gudjohnsen S; Wang E; Mirchandani D; Tibbens A; Lamichhane TN; Lukashevich IS; Comer JE; Weaver SC; Pushko P
Vaccine; 2020 Apr; 38(17):3378-3386. PubMed ID: 32085953
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
[TBL] [Abstract][Full Text] [Related]
11. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
[TBL] [Abstract][Full Text] [Related]
12. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
Turell MJ; Parker MD
Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
Phillpotts RJ; Lescott TL; Jacobs SC
Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
15. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
[TBL] [Abstract][Full Text] [Related]
16. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.
Braid LR; Hu WG; Davies JE; Nagata LP
Stem Cells Transl Med; 2016 Aug; 5(8):1026-35. PubMed ID: 27334491
[TBL] [Abstract][Full Text] [Related]
17. Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood.
Erwin-Cohen RA; Porter AI; Pittman PR; Rossi CA; DaSilva L
Hum Vaccin Immunother; 2017 Jan; 13(1):169-179. PubMed ID: 27870591
[TBL] [Abstract][Full Text] [Related]
18. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
19. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
Elvin SJ; Bennett AM; Phillpotts RJ
J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
[TBL] [Abstract][Full Text] [Related]
20. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models.
Pratt WD; Davis NL; Johnston RE; Smith JF
Vaccine; 2003 Sep; 21(25-26):3854-62. PubMed ID: 12922119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
